Samella buys NVS 89.71: Pharma Equities Technical Analysis -- Sanofi, AstraZeneca, Novartis, Salix Pharma, and AcelRx Pharma
AZN), Novartis AG (NYSE: NVS), Salix Pharmaceuticals Ltd (NASDAQ: SLXP), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX). Free research on these five companies can be accessed at: At Investor-Edge, we provide our members with a simple and reliable way to .. ...
27 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home